influenza
epidem
perenni
result
signific
morbid
mortal
immunocompromis
popul
particularli
high
risk
iav
infect
viral
hemagglutinin
ha
protein
bind
host
cell
receptor
upon
endocytosi
endosom
acidif
ha
protein
undergo
conform
chang
lead
fusion
viral
host
membran
viral
ribonucleoprotein
vrnp
enter
cytosol
transloc
nucleu
commenc
replic
medina
compris
famili
restrict
factor
possess
broad
antivir
activ
brass
et
al
jiang
et
al
mudhasani
et
al
activ
iav
resid
late
endosom
lysosom
locat
cell
surfac
block
hepat
c
viru
hcv
filovirus
ebola
marburg
feeley
et
al
huang
et
al
wilkin
et
al
ifitm
protein
member
protein
superfamili
contain
two
intramembran
domain
travers
cytosolicfac
leaflet
lipid
bilay
join
conserv
intracellular
loop
yount
et
al
play
critic
role
vivo
mice
succumb
normal
mild
iav
infect
bailey
et
al
everitt
et
al
furthermor
individu
variant
like
suffer
wors
cours
influenza
everitt
et
al
zhang
et
al
account
vitro
protect
effect
interferon
ifn
iav
block
viral
particl
fusion
subsequ
endocytosi
therebi
prevent
cytosol
entri
nuclear
transloc
vrnp
feeley
et
al
huang
et
al
weidner
et
al
ifitm
thu
repres
restrict
factor
famili
grow
translat
import
protect
host
earliest
stage
infect
diamond
farzan
perreira
et
al
sever
effort
recent
investig
mechan
ifitmmedi
restrict
exampl
report
ifitm
decreas
membran
fluiditi
block
viralenvelopeinduc
hemifus
latter
conclus
predic
allevi
ifitm
block
celltocel
fusion
oleic
acid
li
et
al
moreov
postul
ifitm
inhibit
vsvgmediat
fusion
disrupt
normal
lipid
traffick
result
elev
level
cholesterol
late
endosom
lysosom
membran
aminibavilolyae
et
al
last
observ
may
aris
direct
interact
domain
endocyt
traffick
protein
vesicleassoci
membran
protein
vapa
ifitm
bind
vapa
may
interfer
interact
vapa
oxysterol
bind
protein
osbp
known
regul
cholesterol
traffick
wyle
et
al
therefor
ifitm
envis
compet
osbp
bind
vapa
produc
elev
level
cholesterol
block
viral
fusion
treat
fungal
infect
tissu
cultur
cell
antimycot
amphob
notic
previou
differ
level
iav
infect
due
differ
level
surprisingli
eras
amphob
use
treat
system
fungal
infect
includ
aspergillosi
sinc
clinic
formul
current
use
wide
treat
grow
number
case
bellmann
amphob
mechan
action
thought
involv
bind
fungal
membran
constitu
ergosterol
lead
pore
format
ion
egress
bolard
clinic
amphob
treatment
produc
sever
side
effect
format
membranespan
pore
increas
diamet
function
concentr
low
concentr
permit
na
k
travers
higher
level
allow
passag
larger
cation
eg
overcom
toxic
two
liposom
prepar
amphob
ambisom
abelcet
develop
manifest
reduc
side
effect
preferenti
target
fungal
membran
ambisom
thu
firstlin
therapi
system
fungal
infect
estim
million
annual
sale
worldwid
moen
et
al
note
commenc
investig
amphob
report
increas
iav
replic
vitro
howev
mechan
vivo
implic
phenomenon
remain
obscur
roethl
et
al
therefor
intrigu
observ
regard
neutral
amphob
pursu
studi
elucid
mechan
interact
potenti
vivo
consequ
investig
observ
regard
amphob
first
evalu
effect
amphob
iav
replic
ifitmdeplet
cell
hela
cervic
adenocarcinoma
cell
stabli
transduc
either
two
short
hairpin
rna
shrna
target
two
neg
control
shrna
firefli
luciferas
figur
hela
cell
chosen
express
rel
high
level
endogen
differ
endogen
level
strongli
correl
amphob
effect
iav
replic
feeley
et
al
roethl
et
al
cell
line
challeng
either
two
strain
iav
without
amphob
loss
untreat
cell
increas
infect
virus
enhanc
greater
cell
treat
amphob
saw
increas
infect
modest
addit
increas
replic
respect
suggest
major
amphob
enhanc
iav
infect
due
overcom
ifitm
act
viral
envelop
proteindepend
stage
entri
block
fusion
therefor
test
effect
amphob
infect
viral
pseudoparticl
express
protein
consist
overcom
amphob
treatment
enhanc
infect
haexpress
particl
figur
notabl
infect
particl
bear
uniqu
increas
vector
cell
treat
amphob
suggest
residu
infect
seen
iav
use
cell
figur
result
intrins
properti
envelop
interestingli
modestli
inhibit
vsvg
pseudoparticl
infect
block
allevi
amphob
next
test
human
lung
carcinoma
cell
express
high
level
exogen
observ
amphob
produc
mark
revers
restrict
hr
postinfect
figur
figur
similar
result
seen
influenza
b
viru
data
shown
due
decreas
toxic
liposom
prepar
amphob
ambisom
use
treat
patient
fungal
infect
therefor
investig
ambisom
also
rescu
iav
infect
case
ambisom
effect
restrict
indistinguish
amphob
clinic
relev
concentr
figur
notabl
therapeut
administ
maxim
concentr
amphob
ambisom
rang
bellmann
given
role
ifn
respons
determin
effect
ambisom
restrict
iav
figur
inhibit
iav
infect
vector
cell
addit
ambisom
rescu
iav
infect
consist
ifn
respons
lost
deplet
brass
et
al
thu
ambisom
remov
major
ifn
protect
iav
vitro
basic
amin
mycosamin
amphob
critic
antimycot
activ
volmer
carreira
amin
proton
physiolog
ph
make
key
interact
lipid
bilay
consequ
synthes
incorpor
addit
cation
site
mycosamin
figur
inde
compound
display
antifung
activ
paquet
et
al
treatment
cell
result
complet
loss
restrict
show
compound
potent
amphob
lower
figur
togeth
data
suggest
chemic
moieti
requir
antifung
properti
compound
also
import
allevi
antivir
action
block
iav
fusion
prevent
vrnp
transloc
nucleu
feeley
et
al
examin
effect
amphob
iav
vrnp
nuclear
transloc
figur
start
infect
iav
nucleoprotein
np
associ
vrnp
immunostain
np
follow
vrnp
distribut
intracellularli
helavector
cell
chill
ice
iav
next
viral
supernat
replac
warm
media
min
indic
time
warm
cell
evalu
np
signal
confoc
microscop
vrnp
arriv
nuclei
min
vector
cell
np
signal
increas
min
event
inhibit
overexpress
remark
treat
cell
line
amphob
vector
cell
show
strong
increas
vrnp
particl
nuclei
although
vector
cell
still
infect
min
time
addit
experi
show
amphob
effect
maxim
ad
min
prior
viral
addit
consist
inhibit
figur
immunoblot
reveal
amphob
treatment
decreas
level
figur
togeth
pseudoparticl
experi
data
demonstr
amphob
enhanc
iav
infect
aris
overcom
inhibit
viral
fusion
determin
specif
amphob
action
compar
effect
cell
stabli
express
experi
show
amphob
effect
counteract
neutral
consider
less
increas
infect
observ
figur
next
chimer
ifitm
protein
construct
find
region
confer
amphob
sensit
john
et
al
ntermin
domain
ntd
fuse
remain
portion
gener
ntd
fuse
produc
figur
chimera
less
affect
amphob
treatment
similar
wildtyp
wt
protein
render
ineffect
amphob
figur
level
wt
ifitm
protein
cell
line
use
experi
purpos
match
express
level
chimera
result
less
restrict
seen
higherexpress
cell
line
figur
result
reveal
amphob
impact
greater
suscept
resid
amino
acid
mechan
restrict
fulli
understood
given
amphob
revers
inhibit
viral
replic
set
use
molecular
probe
investig
action
iav
fusion
requir
endosom
acidif
block
iav
fusion
increas
intracellular
acid
expand
late
endosom
lysosom
compart
feeley
et
al
therefor
might
inhibit
iav
alter
endosom
ph
test
idea
helavector
cell
stabli
transduc
fluoresc
protein
identifi
late
endosom
lysosom
cell
line
incub
mixtur
two
dextran
conjug
either
phsensit
phinsensit
fluor
presenc
absenc
amphob
calcul
ratio
two
signal
allow
us
determin
increas
acid
compart
figur
addit
amphob
modestli
decreas
rel
acid
vector
cell
line
next
evalu
consequ
amphob
alter
ph
acidinduc
ha
activ
indic
time
initi
synchron
infect
immunostain
presenc
ha
undergon
acidinduc
conform
chang
requir
fusion
figur
experi
show
acidinduc
ha
signal
cell
consist
higher
acid
howev
observ
appreci
chang
level
acidinduc
ha
upon
amphob
treatment
either
cell
line
along
dextran
np
transloc
studi
result
suggest
amphob
prevent
restrict
decreas
endosom
acid
studi
also
show
level
locat
alter
amphob
treatment
without
viral
infect
amphob
pore
permit
diffus
ion
across
membran
bolard
endosom
membran
potenti
ion
concentr
na
k
play
role
endocytosi
viralhost
membran
fusion
heleniu
et
al
scott
gruenberg
therefor
examin
amphob
influenc
endosom
na
level
vector
cell
treat
amphob
nystatin
relat
heptaen
three
na
ionophor
incub
cellimperm
fluoresc
indic
asant
na
green
remain
endocyt
compart
permit
visual
na
level
vital
endosom
cell
show
higher
signal
vector
normal
maximum
intens
cell
vector
p
valu
figur
indic
increas
endosom
salin
well
acid
addit
indic
compound
reduc
intens
na
signal
cell
line
howev
loss
restrict
seen
amphob
nystatin
treatment
ionophor
figur
therefor
amphob
diminish
endosom
na
concentr
alon
unlik
explain
counteract
restrict
nystatin
poreform
heptaen
like
amphob
compound
found
rescu
iav
infect
contrast
ionophor
form
pore
instead
transport
na
encas
ion
shuttl
across
bilay
figur
differ
suggest
egress
combin
ion
cybulska
et
al
hartsel
et
al
pore
may
alter
membran
properti
underli
amphob
negat
investig
use
two
small
molecul
tetraethylammonium
tea
acetylcholin
ach
block
amphob
pore
brutyan
mcphie
terazima
yoshino
figur
first
determin
condit
tea
ach
prevent
amphobmedi
efflux
na
endosom
figur
quantit
provid
figur
importantli
assum
result
diffus
addit
ion
ie
k
amphob
pore
also
block
support
tea
also
diminish
modest
chang
endosom
acid
observ
addit
amphob
figur
next
use
condit
challeng
vector
cell
iav
found
blockad
amphob
pore
either
tea
ach
effect
amphob
rescu
iav
replic
figur
argu
alter
endosom
ion
concentr
pore
conduct
account
either
restrict
negat
amphob
amphob
bind
cholesterol
overcom
restrict
intrigu
recent
studi
regard
ifitm
vapa
cholesterol
oleic
acid
therefor
test
role
factor
inhibit
iav
infect
confoc
imag
use
cholesterolbind
fluoresc
probe
filipin
confirm
overexpress
either
increas
intracellular
cholesterol
figur
aminibavilolyae
et
al
howev
lower
level
intracellular
cholesterol
cell
use
lovastatin
result
appreci
differ
restrict
iav
without
amphob
treatment
figur
addit
cholesterol
slightli
decreas
infect
vector
cell
halv
amphob
allevi
restrict
although
rule
latter
result
occur
excess
cholesterol
prevent
amphob
reach
effect
intracellular
concentr
notabl
treatment
cell
line
oleic
acid
effect
either
restrict
iav
figur
overexpress
vapa
cell
vapa
alon
hela
cell
gener
modest
allevi
restrict
either
iav
iav
infect
figur
neimanpick
type
fibroblast
contain
mutat
result
high
level
cholesterol
late
endosom
lysosom
membran
characterist
diminish
iav
infect
figur
aminibavilolyae
et
al
last
three
alanin
scan
mutant
protein
possess
six
contigu
residu
chang
alanin
collect
span
region
interact
vapa
loss
restrict
compar
wt
respect
mutat
result
alter
lysosom
cholesterol
level
figur
john
et
al
data
suggest
neither
vapa
cholesterol
allevi
block
hemifus
oleic
acid
play
substanti
role
either
restrict
iav
revers
amphob
ifitm
protein
associ
form
homo
heteromer
complex
via
domain
interact
requir
restrict
iav
john
et
al
prompt
us
hypothes
multimer
ifitm
protein
inhibit
viral
fusion
alter
fluiditi
cell
membran
test
idea
measur
membran
fluiditi
cell
stabli
express
use
fluoresc
recoveri
photobleach
frap
chose
use
cell
stabli
transduc
due
planar
morpholog
predominantli
cellsurfac
express
compar
resid
late
endosom
lysosom
amen
frap
studi
due
small
size
continu
movement
data
shown
figur
figur
caveolin
chosen
control
similar
intramembran
topolog
ifitm
hoop
et
al
yount
et
al
incub
cell
along
fluoresc
membran
probe
dio
photobleach
area
cell
surfac
white
squar
figur
monitor
return
dio
signal
readout
membran
fluiditi
captur
serial
imag
bleach
area
figur
experi
show
decreas
membran
fluiditi
compar
vector
cell
signifi
slower
recoveri
greater
increas
immobil
fraction
cell
figur
consist
previou
report
contrast
express
increas
membran
fluiditi
demonstr
specif
action
cai
et
al
test
function
effect
emul
eleg
studi
establish
iav
fusogen
virus
induc
tissu
cultur
cell
form
syncytia
expos
low
ph
white
et
al
incub
cell
line
vector
concentr
iav
ice
follow
addit
warm
buffer
either
ph
replac
buffer
media
stain
cell
actin
dna
follow
imag
analysi
quantit
syncytia
base
cluster
nuclei
absenc
interven
band
actin
figur
show
less
fusion
event
occur
among
cell
fuse
cell
compar
either
cell
vector
control
cell
fuse
cell
p
figur
interpret
lack
effect
assay
attribut
locat
late
endosom
lysosom
level
exogen
express
protein
seen
compar
immunoblot
figur
amphob
alter
either
effect
membran
fluiditi
antifus
action
figur
although
altogeth
unexpect
given
amphob
weak
effect
restrict
therefor
conclud
decreas
membran
fluiditi
along
increas
resist
iavinduc
celltocel
fusion
data
demonstr
amphob
increas
iav
replic
overcom
protect
effect
vitro
determin
effect
amphob
iav
vivo
infect
either
wt
knockout
mice
lowpathogen
strain
iav
everitt
et
al
dose
use
strain
produc
mild
ill
wt
mice
made
full
recoveri
figur
contrast
consist
previou
studi
infect
mice
lost
bodi
weight
sign
signific
ill
day
postinfect
notabl
wt
litterm
treat
ambisom
mgkg
inject
day
rel
viral
inocul
behav
ident
mice
experienc
clinic
cours
usual
observ
pathogen
strain
iav
manifest
sever
symptom
conjunct
weight
loss
exceed
start
valu
saw
sign
ill
ambisom
treatment
alon
absenc
infect
figur
evalu
lung
patholog
day
postinfect
show
mark
edema
pneumonia
hemorrhag
substanti
inflamm
ambisometr
infect
mice
either
wt
compar
wt
mice
expos
ambisom
figur
inde
set
infect
littl
differ
seen
compar
ambisometr
wt
lung
one
anim
consist
result
mous
embryon
fibroblast
mef
deriv
mice
suscept
infect
wt
mef
differ
larg
eras
amphob
exposur
figur
e
similar
cell
treat
amphob
demonstr
slightli
increas
infect
suggest
addit
compon
also
overcom
amphob
conclud
clinic
formul
amphob
ambisom
produc
function
equival
state
convert
mild
ill
lifethreaten
infect
began
studi
observ
treat
cell
amphob
prevent
restrict
upon
investig
phenomenon
found
overcom
princip
compon
amphobenhanc
iav
infect
confirm
significantli
extend
previou
studi
report
investig
roethl
et
al
consequ
also
show
neutral
block
viral
fusion
amphob
remov
ifn
protect
effect
iav
vitro
also
use
amphob
molecular
probe
investig
mechan
restrict
determin
increas
endosom
acid
salin
event
unlik
play
major
role
restrict
instead
properti
may
aris
mechan
specif
ifitm
alter
physic
properti
membran
support
idea
determin
decreas
membran
fluiditi
event
associ
inhibit
iavinduc
celltocel
fusion
data
consist
recent
gener
use
ortholog
approach
li
et
al
collect
find
sever
implic
first
decreas
membran
fluiditi
ifitm
may
imped
sequenti
assembl
viralhost
receptor
complex
therebi
block
viral
entri
virus
reli
multipl
receptor
entri
would
suscept
effect
eg
hcv
consist
inhibit
hcv
schoggin
et
al
wilkin
et
al
separ
studi
report
restrict
mobil
one
two
host
receptor
inhibit
viral
fusion
rawat
et
al
similarli
recent
work
elegantli
shown
cluster
multipl
viral
envelop
need
iav
entri
suggest
activ
may
hinder
ifitm
resid
hostderiv
viral
andor
host
membran
ivanov
et
al
second
ifitm
homo
heterom
within
membran
may
stabil
membran
complex
inhibit
dissoci
ie
stabil
vacuolar
atpas
may
increas
endosom
acid
potenti
salin
wee
et
al
third
insert
ifitm
im
domain
cytosolicfac
leaflet
membran
may
produc
posit
curvatur
bilay
well
describ
membraneassoci
protein
callanjon
bassereau
nikolau
herrmann
voeltz
et
al
yount
et
al
therefor
produc
concav
rigid
membran
ifitm
protein
may
creat
barrier
viral
fusion
machineri
notabl
use
gener
strategi
protect
oneself
mani
virus
would
produc
multipl
fit
advantag
given
model
restrict
favor
scenario
wherein
amphob
rescu
iav
replic
increas
membran
fluiditi
planar
would
permit
viralhost
receptor
interact
pore
format
support
notion
report
amphob
enhanc
membran
fluiditi
abusalah
et
al
younsi
et
al
mention
amphob
first
bind
cholesterol
lipid
bilay
form
transmembran
pore
cation
analog
amphob
potent
like
aris
improv
hydrogenbond
abil
could
augment
either
channel
format
interact
neg
charg
phospholipid
increas
membran
fluiditi
shown
block
pore
conduct
alter
amphob
effect
restrict
therefor
fenestr
lipid
bilay
pore
form
either
amphob
may
increas
membran
fluiditi
addit
presenc
heptaen
membran
may
disrupt
cholesterolphospholipid
interact
andor
ifitm
interact
lead
increas
membran
flexibl
figur
support
last
assert
found
ad
addit
cholesterol
reduc
half
allevi
restrict
amphob
note
howev
amphob
littl
allevi
either
antivir
action
inhibitori
effect
membran
fluiditi
celltocel
fusion
therefor
addit
effort
need
determin
effect
plasma
membran
fluiditi
effect
endosom
membran
amphob
antagon
result
alter
membran
fluiditi
regard
unsur
amphob
specif
overcom
leav
action
predominantli
extant
one
factor
may
proxim
amphob
endocytos
quit
rapidli
lead
concentr
late
endosom
lysosom
area
highest
concentr
futur
studi
use
deriv
amphob
ifitm
mutant
protein
use
test
model
intrigu
recent
report
test
role
vapa
cholesterol
oleic
acid
restrict
overexpress
vapa
modestli
decreas
restrict
iav
assay
base
use
cell
line
antibodi
vapa
semin
report
estim
overexpress
vapa
met
surpass
publish
level
modul
cholesterol
level
appreci
effect
restrict
suggest
cholesterol
misloc
contribut
vapa
antagon
furthermor
cell
express
either
three
protein
contain
mutat
span
report
interact
domain
vapa
exhibit
wt
level
restrict
intracellular
cholesterol
result
suggest
direct
interact
vapa
underli
subtl
effect
vapa
restrict
mention
howev
alanin
scan
strategi
may
conserv
hydrophob
domain
also
address
role
oleic
acid
overcom
ifitmmedi
inhibit
celltocel
fusion
specif
found
oleic
acid
overcom
restrict
iav
vitro
condit
test
furthermor
oleic
acid
overcom
inhibit
celltocel
fusion
assay
iav
particl
data
shown
therefor
recent
report
improv
understand
restrict
conclud
addit
mechanist
studi
requir
found
amphob
prevent
antivir
action
suggest
patient
treat
amphob
formul
might
greater
risk
influenza
everitt
et
al
therefor
test
clinic
prepar
amphob
ambisom
vivo
found
similar
mice
wt
litterm
treat
ambisom
develop
sever
ill
normal
nonpathogen
iav
strain
individu
variant
like
hospit
influenza
suggest
play
role
protect
human
popul
everitt
et
al
inde
allel
recent
report
convey
larg
populationattribut
risk
chines
popul
zhang
et
al
moreov
critic
protect
resid
memori
cell
popul
iav
infect
vivo
argu
amphob
antagon
may
impair
adapt
immun
system
well
wakim
et
al
collect
data
suggest
patient
receiv
antifung
therapi
liposom
amphob
may
function
immunosuppress
therefor
vulner
influenza
mani
patient
receiv
ambisom
lost
adapt
innat
immun
defens
role
intrins
immun
factor
may
critic
protect
iav
moen
et
al
addit
patient
also
prophylact
ambisom
therapi
may
potenti
incur
greater
iav
infect
risk
hope
report
mechan
vivo
consequ
interact
amphotericin
b
may
help
stimul
translat
studi
potenti
guid
patient
care
tetraethylammonium
tea
sigma
acetylcholin
ach
sigma
incub
cell
without
amphob
hr
prior
infect
infect
cell
incub
hr
fix
analyz
describ
previous
experi
detect
np
nuclear
transloc
acidinduc
ha
conform
chang
modifi
previous
describ
experi
feeley
et
al
nuclear
transloc
vrnp
quantifi
analyz
imag
use
imari
bitplan
scientif
softwar
previous
describ
vector
cell
viru
chill
ice
addit
viru
cell
white
et
al
viru
cell
incub
min
cell
rins
incub
ph
ph
buffer
mm
me
mm
hepe
pb
min
subsequ
buffer
replac
warm
media
cell
incub
incub
addit
hr
cell
fix
paraformaldehyd
permeabil
triton
stain
alexa
fluor
phalloidin
life
technolog
hoechst
invitrogen
imag
fusion
event
identifi
base
format
syncytia
nuclear
aggreg
percentag
fusion
calcul
use
ratio
nuclei
within
fuse
cell
total
nuclei
microscop
field
evalu
five
field
examin
experiment
condit
cell
plate
glassbottom
dish
mattek
hr
prior
analysi
cell
pretreat
fresh
media
fresh
media
contain
amphob
hr
stain
vibrant
dii
dio
invitrogen
min
wash
pb
twice
frap
done
cell
use
leica
leica
frap
wizard
least
ten
cell
measur
per
experi
la
af
lite
leica
softwar
use
quantifi
intens
photobleach
area
total
cell
fluoresc
area
outsid
cell
normal
normal
intens
photobleach
area
averag
togeth
form
repres
curv
condit
cell
plate
onto
chamber
coverglass
slide
thermo
fisher
scientif
cultur
overnight
imag
cell
incub
hr
yellowblu
dextran
life
technolog
mw
asant
sodium
green
teflab
presenc
absenc
amphob
ionophor
amphob
tea
ach
cell
visual
confoc
microscopi
ratiometr
dextran
experi
calcul
averag
ratio
phsensit
dextran
signal
phinsensit
dextran
signal
compart
normal
ratio
determin
control
cell
backgroundmatch
wildtyp
mice
everitt
et
al
week
age
maintain
accord
uk
home
offic
regul
uk
anim
scientif
procedur
act
project
licens
everitt
et
al
licens
review
wellcom
trust
sanger
institut
ethic
review
committe
group
five
isofluraneanaesthet
mice
genotyp
intranas
inocul
plaqueform
unit
influenza
steril
pb
everitt
et
al
day
ambisometr
mice
wildtyp
match
administ
mgkg
ambisom
gilead
intraven
weight
record
daili
monitor
sign
ill
mice
exceed
total
weight
loss
euthan
accord
uk
home
offic
guidelin
litterm
control
use
experi
